A venture capital firm with offices in the US looks to invest in diagnostics companies addressing gaps and answering problems present in the current market. The firm really looks to fund companies with a large market need. The firm invests exclusively in Seed to Series A rounds, with the ability for follow-on investments. The firm typically invests $1M-5M in the form of equity, with the ability to go up to $10M. The firm invests globally.
The firm is solely focused on diagnostics companies. The firm is indication- and modality- agnostic, and open to all classes of diagnostics. The firm can also invest in associated data tools; however, their focus lies in diagnostics companies. The firm invests in pre-commercial companies.
The firm typically co-invests. The firm likes to see management teams with diagnostic industry experience. The firm considers themselves “hands-on” investors, able to provide specific industry experience.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment